Drug Discovery · Medfield, MA · Founded 2020 · Privately Held (backing)
Developer of respiratory drugs designed for novel therapeutics for patients affected by intractable diseases. Kinaset Therapeutics is based in Medfield, MA and was founded in 2020. It was valued at $186 million at its later-stage round in Jan 2026, the last priced event on record. It has raised $143 million across 3 recorded rounds; the latest was a $103 million Series B in Jan 2026.
PMV mark · valuation
$186.0M
Oct 2026
Priced at
its later-stage round
Jan 2026
Total raised
$143.0M
Last round
Later Stage VC (Series B)
Jan 2026
No prints on record
No secondary trades in Kinaset Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kinaset Therapeutics with a free account
·The complete investor list: 12 names
·Watch Kinaset Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Kinaset Therapeutics stock.
